C81.20

Clinical Causes: Genetic mutations that affect immune cell regulation Previous exposure to certain viruses, such as the Epstein-Barr virus (EBV) Weakened immune system due to HIV/AIDS or immunosuppressive treatments Environmental factors like exposure to certain chemicals or toxins

Key Symptoms: Swollen lymph nodes, often painless and located in the neck, armpit, or groin Unexplained weight loss Persistent fever not caused by infections Night sweats Fatigue or weakness Itching skin, without an apparent cause Persistent cough or chest pain if the lymphoma involves the mediastinum Pain or discomfort in affected lymph areas after alcohol consumption (less common)

Diagnosis Path: Diagnosing mixed cellularity Hodgkin lymphoma typically involves multiple steps: - **Physical examination:** Checking for enlarged lymph nodes or other signs. - **Imaging tests:** Such as CT scans, PET scans, or X-rays to identify the extent and location of lymphoma. - **Biopsy:** Removal of a lymph node or tissue sample for microscopic examination to identify Reed-Sternberg cells and other abnormal cells. - **Laboratory tests:** Blood tests to assess overall health, organ function, and presence of specific markers. - **Additional assessments:** Bone marrow biopsies or assessment of other affected organs may be necessary to stage the disease. This comprehensive approach helps in confirming the diagnosis and planning appropriate treatment strategies.

Treatment Protocols: Treatment options for mixed cellularity Hodgkin lymphoma often involve a combination of therapies: - **Chemotherapy:** The primary treatment, often using regimens like ABVD (Adriamycin, Bleomycin, Vinblastine, Dacarbazine) to kill cancer cells. - **Radiation therapy:** Used in localized cases to target affected areas. - **Targeted therapy:** Drugs that target specific molecules involved in cancer growth. - **Stem cell transplant:** Considered for advanced or refractory cases to restore healthy blood cell production. - **Supportive care:** Includes management of side effects, infection prevention, and nutritional support. Prognosis depends on various factors, including the stage at diagnosis and overall health. Early detection and tailored treatment plans are critical in improving outcomes for patients with this lymphoma.